Vaginal/vulvar symptoms with lasofoxifene versus fulvestrant in ESR1-Mutated, Er+/Her2-metastatic breast cancer patients Meeting Abstract
| Authors: | Goldfarb, S. B.; Sammons, S. L.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B.; Carroll, D.; Portman, D. J. |
| Abstract Title: | Vaginal/vulvar symptoms with lasofoxifene versus fulvestrant in ESR1-Mutated, Er+/Her2-metastatic breast cancer patients |
| Meeting Title: | 2023 Annual Meeting of the International Society for the Study of Women's Sexual Health (ISSWSH) |
| Journal Title: | Journal of Sexual Medicine |
| Volume: | 20 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 19-22 |
| Meeting Location: | Scottsdale, AZ |
| ISSN: | 1743-6095 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-05-01 |
| Start Page: | ii63 |
| End Page: | ii64 |
| Language: | English |
| ACCESSION: | WOS:001043080700111 |
| PROVIDER: | wos |
| DOI: | 10.1093/jsxmed/qdad061.110 |
| Notes: | Meeting Abstract: 114 -- Source: Wos |
